COMMUNIQUÉS West-GlobeNewswire

Cyclacel Pharmaceuticals Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:05

BERKELEY HEIGHTS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target [...]

Zosano Pharma Reports Third Quarter 2017 Financial Results and Operational Update

09/11/2017 - 22:05

First patient enrolled in long term safety study in November 2017 Phase 2/3 data presented at International Headache Society in September Clinical results published in two leading scientific journals Access to capital [...]

Yield10 Bioscience Announces Third Quarter 2017 Financial Results

09/11/2017 - 22:03

WOBURN, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today reported financial results for the three and nine months ended September 30, 2017. “Over the course of 2017 we have focused [...]

CareDx Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:02

BRISBANE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Avinger Announces Third Quarter 2017 Results

09/11/2017 - 22:01

REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported [...]

Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update

09/11/2017 - 22:01

Initiated a Phase 2 clinical trial with NasoVAX vaccine with initial data expected in first quarter 2018 Completed enrollment in its Phase 1 HepTcell clinical trial with data expected in fourth quarter 2017 Conference [...]

Stemline Therapeutics Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:01

NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today financial [...]

Endocyte to Present at the Jefferies 2017 London Healthcare Conference

09/11/2017 - 22:01

WEST LAFAYETTE, Ind., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]

Cellectar Biosciences Reports Third Quarter 2017 Financial and Corporate Performance

09/11/2017 - 22:01

MADISON, Wis., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), an oncology-focused, clinical stage biotechnology company (the “company”), today reported financial results and corporate [...]

Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates

09/11/2017 - 22:01

Received FDA Clearance of IND Application for XMT-1536, a First-in-Class Dolaflexin® Antibody Drug Conjugate Targeting NaPi2b XMT-1522 Phase 1 Trial Continues Enrollment of Patients with Advanced Tumors Expressing HER2 [...]

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results

09/11/2017 - 22:01

ANN ARBOR, Mich., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V: ZOM ) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed [...]

Bio-Path Holdings Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:01

HOUSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]

AveXis Reports Third Quarter 2017 Financial and Operating Results

09/11/2017 - 22:00

– First patient has been dosed in pivotal trial of AVXS-101 for SMA Type 1 – – Conference call and webcast November 9 at 4:30 p.m. EST – CHICAGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a [...]

Major Shareholder Announcement

09/11/2017 - 20:33

Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; November 9, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the Danish Securities Trading Act [...]

Sharecare Ranked Among Fastest Growing Companies in North America on Deloitte’s 2017 Technology Fast 500™

09/11/2017 - 20:27

ATLANTA, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sharecare , the digital health company that helps people manage all their health in one place, today announced it was named to Deloitte’s Technology Fast 500™, a ranking of the [...]

NANOBIOTIX : Point sur le développement global du produit NBTXR3

09/11/2017 - 20:14

Nanobiotix : Point sur le développement global du produit NBTXR3 Deux présentations d'Immuno-oncologie lors de la conférence Society for Immunotherapy of Cancer (SITC) en novembre ; Données de tolérance, de sécurité et [...]

NANOBIOTIX provides update on the global development of its lead product NBTXR3

09/11/2017 - 20:14

Nanobiotix provides update on the global development of its lead product NBTXR3 Nanobiotix will give two immuno-oncology presentations at the Society for Immunotherapy of Cancer (SITC) conference this month Tolerability [...]

Skyline Medical Inc. Signs Distribution Agreement to Market STREAMWAY System in Australia and New Zealand

09/11/2017 - 19:30

MINNEAPOLIS, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

United Health Products Inc. Announces Hemostyp® as featured product of Dick’s Sporting Goods Advanced Wound Care Kit

09/11/2017 - 18:59

HENDERSON, Nev., Nov. 09, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCQB:UEEC) announced that their 2’ x 4” trauma gauze product has been selected as the feature component for a new Advanced Wound care kit [...]